Cited by 598Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAcute Ischemic Stroke Management

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

National Trends in Ambulatory Oral Anticoagulant Use

Open access

Barnes, Geoffrey D., Lucas, Eleanor, Alexander, G. Caleb, Goldberger, Zachary D.·2015·The American Journal of Medicine

DOI 10.1016/j.amjmed.2015.05.044PMC PMC4658248

Open this paper in CoChat — free account Open PDF

Abstract

Background Four direct oral anticoagulants (DOACs) have been brought to market for the treatment of nonvalvular atrial fibrillation and venous thromboembolism. Many forces, including numerous positive trial results, emerging safety concerns, marketing, and promotion, may shape DOAC adoption by providers. However, relatively little is known regarding their ambulatory utilization compared with warfarin, as well as the degree to which they have decreased under-treatment of atrial fibrillation.Methods We used the IMS Health National Disease and Therapeutic Index, a nationally representative audit of outpatient office visits, to estimate the use of warfarin and DOACs between 2009 and 2014.Results Overall, visits with anticoagulation use increased from 2.05 (95% confidence interval [CI], 1.82-2.27) to 2.83 (95% CI, 2.49-3.17) million (M) quarterly visits (P < .001). Of these, DOAC use has grown to 4.21M (95% CI, 3.63M-4.79M; 38.2% of total) treatment visits in 2014 since their introduction in 2010. Use of all oral anticoagulants in treatment visits for atrial fibrillation has increased from 0.88M (95% CI, 0.74M-1.02M) to 1.72M (95% CI, 1.47M-1.97M; P < .001), with similar DOAC and warfarin use in 2014. Atrial fibrillation visits with anticoagulant use increased from 51.9% (95% CI, 50.4%-53.8%) to 66.9% (95% CI, 65.0%-69.3%) between 2009 and 2014 (P < .001). In 2014, rivaroxaban was the most commonly prescribed DOAC for atrial fibrillation (47.9% of office visits), followed by apixaban (26.5%) and dabigatran (25.5%).Conclusions Direct oral anticoagulants have been adopted rapidly, matching the use of warfarin, and are associated with increased use of oral anticoagulation for patients with atrial fibrillation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2015.05.044

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION
Tarver, T. (2014) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,595
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.025 · Cited by 929

Show all 41 references

Sorted by citations

Items 401–500 of 597

Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice
Sherwood, M. W., Piccini, J. P., Holmes, D. N., Pieper, K. S., Steinberg, B. A., Fonarow, G. C., Allen, L. A., Naccarelli, G. V., Kowey, P. R., Gersh, B. J., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008274 · Cited by 3
No Association between Gastrointestinal Rebleeding and DOAC Therapy Resumption: A Systematic Review and Meta-Analysis
Pálinkás, D., Teutsch, B., Gagyi, E. B., Engh, M. A., Kalló, P., Veres, D. S., Földvári-Nagy, L., Hosszúfalusi, N., Hegyi, P., & Erőss, B. M. (2023) · Biomedicines · doi:10.3390/biomedicines11020554 · Cited by 3
Outcomes of different perioperative management strategies of patients on chronic anticoagulation in elective total hip and knee arthroplasty: a systematic review
Andronic, D., Andronic, O., Ammann, E., Pravin, E., & Cubberley, R. (2024) · Family Practice · doi:10.1093/fampra/cmae020 · Cited by 3
Protocolo de consenso en el tratamiento antitrombótico (anticoagulación y antiagregación) durante el periodo perioperatorio y periprocedimiento en neurocirugía
Arikán, F., Urzaiz, L. L., Alén, J. F., & Laez, R. M. (2017) · Neurocirugía · doi:10.1016/j.neucir.2017.08.001 · Cited by 3
Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation
Aronow, W. S., & Shamliyan, T. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000848 · Cited by 3
Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
Ostroumova, O. D., Volkova, E. A., Кочетков, А. И., Pereverzev, A. P., & Ткачева, О. Н. (2019) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2019-5-128-137 · Cited by 3
Consenso colombiano de cuidados perioperatorios en cirugía cardiaca del paciente adulto
Mendoza, J. L., Atehortua, L. H., Estrada, V. H. N., Carlos Eduardo Rebolledo, M., Pérez, J. C. D., Sénior, J. M., Hernández-Leiva, E., Valencia, A. A., Escobar-Serna, J. F., Castell, C. R. D., et al. (2020) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2020.03.002 · Cited by 4
Partial warfarin reversal prior to hip fracture surgical intervention in geriatric trauma patients effects on blood loss and transfusions
Meinig, R. P., Cornutt, D., Jarvis, S., Salottolo, K., Kelly, M., Harrison, P. D., Nentwig, M., Morgan, S., Nwafo, N., McNair, P. W., et al. (2020) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2020.09.027 · Cited by 3
Role of Inferior Vena Cava Filter Retrieval in Patients on Chronic Anticoagulation Therapy
Fletcher, S., Plotnik, A. N., Srinivasa, R. N., Chick, J. F. B., & Moriarty, J. M. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00891-1 · Cited by 3
The Impact of Antithrombotic Medications on Postoperative Bleeding Events Following Hemorrhoidectomy
Dean, K. R., Pavuluri, H., Fox, S., Tan, X., Watson, B., Wallenborn, J. G., & Blestel, G. A. (2022) · The American Surgeon · doi:10.1177/00031348221124332 · Cited by 3
Risk of Bleeding Among Individuals on Direct-Acting Oral Anticoagulants: An Academic Medical Center Cohort Study
Gómez-Lumbreras, A., Tan, M. S., Moorman‐Bishir, K., Ilham, S., & Malone, D. C. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001347 · Cited by 3
A 65-Year-Old Man with Bilateral Adrenal Hemorrhage Following Prophylaxis for Postoperative Deep Vein Thrombosis with Rivaroxaban
Al-Rawi, S., Seidahmed, M., Emam, S. S., & Othman, E. S. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.939816 · Cited by 3
Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis
Fedina, L. V., Sychev, I. N., Mirzaev, K. B., Vardanyan, A. V., Владимирович, Г. С., Kachanova, A. A., Бочков, П. О., Шевченко, Р. В., Николаевна, Т. С., Sychev, I. V., et al. (2024) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2024-2941 · Cited by 3
Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review
Vazquez, S. R., Yates, N. Y., Beavers, C. J., Triller, D. M., & McFarland, M. (2024) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-024-02991-2 · Cited by 5
Postoperative Hemorrhage and Venous Thromboembolism in Patients with Pituitary Adenomas Under Acetylsalicylic Acid
Tonchev, N., Pinchuk, A., Dumitru, C. A., Stein, K., Neyazi, B., Sandalcioglu, I. E., & Rashidi, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237020 · Cited by 3
Edoxaban-induced acute interstitial nephritis
Gen, S., Higashi, R., Nagae, N., Kigure, R., Kamikubo, Y., Nobe, K., & Ikeda, N. (2025) · CEN Case Reports · doi:10.1007/s13730-025-00974-7 · Cited by 3
Attempted Suicide by Massive Warfarin Ingestion Conservatively Managed Using Phytonadione
March, K. L., Patel, K., & Twilla, J. D. (2016) · Case Reports in Hematology · doi:10.1155/2016/7095251 · Cited by 3
Excessive Prolongation of Coagulation Time During Treatment With Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation
Kawabata, M., Goya, M., Takahashi, Y., Maeda, S., Yagishita, A., Sekigawa, M., Akiyoshi, K., Yamamoto, T., Koyama, T., & Hirao, K. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.02.012 · Cited by 3
Follow-up management of patients receiving direct oral anticoagulants
Fantoni, C., Bertù, L., Galliazzo, S., Pola, R., Pomero, F., Porfidia, A., Porreca, E., Valeriani, E., & Ageno, W. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02433-w · Cited by 3
Trends in anticoagulation management services following incorporation of direct oral anticoagulants at a large academic medical center
Mills, C., Snider, M. J., Ortman, T. C., Dush, A., Hevezi, M. S., Li, J., Weiss, R., & Kraut, E. H. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02286-2 · Cited by 3
Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
Uribe, W., Reyes, J. M., & Gamboa, N. C. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211000213 · Cited by 3
Anticoagulation in Very Old Patients with Atrial Fibrillation (AVOPA): A Descriptive Observational Study
Hupfer, M., & Gosch, M. (2021) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00263-6 · Cited by 3
Thrombocytopenia Due to Direct Oral Anticoagulation and Low-Molecular-Weight Heparin
Tucker, M., & Padarti, A. (2021) · Cureus · doi:10.7759/cureus.18757 · Cited by 3
Resolution of Internal Carotid Arterial Thrombus by the Thrombolytic Action of Dabigatran
Akiyama, H., Hoshino, M., Shimizu, T., & Hasegawa, Y. (2016) · Medicine · doi:10.1097/md.0000000000003215 · Cited by 3
Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation
Sanmartı́n, M., & Marzal-Martín, D. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616668404 · Cited by 3
Prothrombin complex concentrate and fatal thrombotic adverse events: A complication to keep in mind
Tabet, R., Shammaa, Y., Karam, B., Yacoub, H., & Lafferty, J. (2018) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2018.01012 · Cited by 3
Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism
Kelley, D., Wright, L. R., Ohman, K. L., & Ferreira, J. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1682-6 · Cited by 3
Transcatheter Mitral Valve Implantation With the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System
Koh, J. Q., Walton, A., Marasco, S., & Duffy, S. J. (2019) · Future Cardiology · doi:10.2217/fca-2018-0082 · Cited by 3
Perioperative Use of Novel Oral Anticoagulants in Orthopaedic Surgery
Eliasberg, C. D., Levack, A. E., Gausden, E. B., Garvin, S., Russell, L., & Kelly, A. M. (2019) · JBJS Reviews · doi:10.2106/jbjs.rvw.18.00148 · Cited by 3
Effect of CYP2C9 *11/*11 Genotype on Initial and Long-Term Warfarin Dose Requirement and Therapeutic Response
Quinn, A. H., Bhat, S., & Lee, J. C. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0125 · Cited by 3
Antithrombotic regimens and need for critical care interventions among patients with subdural hematomas
Robinson, D., Pyle, L., Foreman, B. P., Ngwenya, L. B., Adeoye, O. M., Woo, D., & Kreitzer, N. P. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.03.035 · Cited by 3
Stroke prevention in atrial fibrillation: can we do better?
Lane, D. A., & Lip, G. Y. H. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.117 · Cited by 3
Management of Chronic Antithrombotic Medication in Total Joint Arthroplasty: A Primer for the Orthopaedic Surgeon
von Treuheim, T. D. P., Ruff, G. L., Shanaa, J., Schwarzkopf, R. M., & Aggarwal, V. K. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.09.020 · Cited by 2
Injuries Due to In-Flight Turbulence During United States Commercial Airline Flights (2008-2023)
Shekhar, A. C., & Ruskin, K. J. (2025) · The American Surgeon · doi:10.1177/00031348251397042 · Cited by 2
Identifying Clinical Predictors of Switching From Direct Oral Anticoagulants to Warfarin
Rollins, A., Hanigan, S., Pogue, K. T., Renner, E., Barnes, G. D., & Dorsch, M. P. (2019) · Clinical Medicine Insights Therapeutics · doi:10.1177/1179559x19831287 · Cited by 2
Self-citation
Associations between anticoagulant treatment pathways and self-reported harms in patients recently diagnosed with venous thromboembolism
Pan, S., Allahwerdy, F., Kim, K., Feehan, M., Jones, A. E., Munger, M. A., & Witt, D. M. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.08.006 · Cited by 2
Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases
Esposti, L. D., Andretta, M., Pasquale, G. D., Gambera, M., Saragoni, S., Perrone, V., & Buda, S. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s216749 · Cited by 2
Efficacy of prothrombin complex concentrate for reversal of major bleeding due to rivaroxaban: A pilot randomized controlled trial
Shadvar, K., Sadaghi, P., Hamishehkar, H., & Mahmoodpoor, A. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.110093 · Cited by 2
Impact of an oral anticoagulation self-monitoring and self-management program in patients with mechanical heart valve prosthesis
Blanch, P., Freixa‐Pamias, R., Gambau, M., Lafuente, R., & Basile, L. (2021) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0215 · Cited by 2
Postmastectomy Breast Reconstruction is Safe in Patients on Chronic Anticoagulation
Yan, M., Kuruoglu, D., Boughey, J. C., Manrique, O. J., Tran, N. V., Harless, C. A., Martinez‐Jorge, J., & Nguyen, M.-D. T. (2022) · Archives of Plastic Surgery · doi:10.1055/s-0042-1744405 · Cited by 2
Management of Haemarthrosis in Patients On Oral Anticoagulants
Dalrymple, J., Davies, A., Biggs, A., Rajcoomar, S., & Gill, I. R. (2022) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/21514593221076966 · Cited by 2
Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation
Keithler, A. N., Wilson, A. S., Yuan, A., Sosa, J. M., & Bush, K. N. V. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049394 · Cited by 2
Andexanet alfa therapy showed No increased rate of thromboembolic events in spontaneous intracranial hemorrhage patients: A multicenter electronic health record study
Vellek, J., Tarawneh, O. H., Kazim, S. F., Owodunni, O. P., Arbuiso, S., Shah, S. P., Dicpinigaitis, A. J., Schmidt, M. H., McKee, R. G., Miskimins, R. J., et al. (2024) · World Neurosurgery X · doi:10.1016/j.wnsx.2024.100367 · Cited by 2
Ocular Neovascular Conversion and Systemic Bleeding Complications in Patients with Age-Related Macular Degeneration on Anticoagulants
Alsoudi, A. F., Koo, E. B., Wai, K. M., Mruthyunjaya, P., & Rahimy, E. (2024) · Ophthalmology · doi:10.1016/j.ophtha.2024.07.034 · Cited by 2
Insights Into the Complexities of Antithrombotic Interactions: A Core–Shell Particle‐Based UHPLC–MS/MS Method to Investigate Dexamethasone's Influence on Apixaban and Rivaroxaban Pharmacokinetics
Sayed, R. M., Mahmoud, S. T., Mostafa, E. A., El-Ashrey, M. K., & Moffid, M. A. (2025) · Separation Science Plus · doi:10.1002/sscp.70009 · Cited by 2
Frontier and hotspot evolution in pulmonary embolism: A bibliometric analysis from 2004 to 2023
Huang, K., Zhu, J., Sun, K., Wang, H., Peng, Y., & Peng, B. (2025) · Medicine · doi:10.1097/md.0000000000042747 · Cited by 2
Direct oral anticoagulant reversal: An update
Hafer, A., & McCann, L. (2021) · Nursing · doi:10.1097/01.nurse.0000743104.69943.67 · Cited by 2
A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?
Douketis, J. D., & Radwi, M. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1930-y · Cited by 2
High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case–Cohort Study
Toorop, M. M. A., van Rein, N., Cannegieter, S. C., van der Meer, F. J. M., Reitsma, P. H., Lijfering, W. M., & Bos, M. H. A. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1715459 · Cited by 2
Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants
Arora, P., Muehrcke, M., Russell, M., & Jayasekare, R. R. (2022) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2021-0307 · Cited by 2
Comparison of the Warfarin Dosing and Outcomes in Hmong Versus East Asians Patients: Real-World Data From an Integrated Healthcare System
Sun, B., Yew, P. Y., Wen, Y., Chi, C., & Straka, R. J. (2022) · Cureus · doi:10.7759/cureus.28905 · Cited by 2
Incidence and Characteristics of Orbital Hemorrhages in the United States from 2006 to 2018
Jensen, A., Taneja, K., Ahmad, M. T., Woreta, F. A., & Rajaii, F. (2022) · Clinical ophthalmology · doi:10.2147/opth.s376447 · Cited by 2
Temporal trends in admissions for atrial fibrillation and severe bleeding in England: an 18-year longitudinal analysis
Seidu, S., Gillies, C., Zaccardi, F., Reeves, K., Gallier, S., & Khunti, K. (2022) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2022.2156597 · Cited by 2
Prognostic Factors to Reduce ICU Overtriage in Elderly Patients with Isolated Mild Traumatic Brain Injury
Jacome, T. H., LaBorde, C., Lewis, R., & Tatum, D. M. (2023) · Surgical Science · doi:10.4236/ss.2023.147057 · Cited by 2
Anticoagulant plus antiplatelet therapy for atrial fibrillation
Bode, K., Hindricks, G., ten Berg, J. M., & Whittaker, P. (2018) · Herz · doi:10.1007/s00059-018-4747-6 · Cited by 2
Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation
Kido, K., Shimizu, M., Shiga, T., & Hashiguchi, M. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.09.003 · Cited by 2
Stratifying Thromboembolic Risk: Why Is Your Patient on Antithrombotic Medications?
Hohlfelder, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-71240-6_8 · Cited by 1
Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
Pillarisetti, J., Reddy, M., Vodapally, M., Annapureddy, T., Molugu, M., Atkins, D., Bommana, S., Pimentel, R., Dendi, R., & Lakkireddy, D. (2020) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2020.08.002 · Cited by 1
Clinical outcomes and predictors of a gap in direct-acting oral anticoagulant therapy in the elderly: A time-varying analysis of a nationwide cohort study
Jung, M., Lee, B., Lee, S., & Shin, J. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.04.018 · Cited by 1
Computational Structural Validation of CYP2C9 Mutations and Evaluation of Machine Learning Algorithms in Predicting the Therapeutic Outcomes of Warfarin
Sridharan, K., Kumar, D. T., Suchetha, M., Prasanna, G., Guruswamy, L., Banna, R. A., & Doss, C. G. P. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230705124329 · Cited by 1
Is It Safe to Resume Direct Oral Anticoagulants upon Discharge after Hip Fracture Surgery? A Retrospective Study
Katzir, A., Fisher-Negev, T., Or, O., Jammal, M., Mosheiff, R., & Weil, Y. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010017 · Cited by 1
Fixed vs Weight-Based Dosing of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Patients With a Non-Neurologic Hemorrhage
Stokes, T., Johnson, C., Fish, T., & Mishler, A. (2025) · Journal of Pharmacy Practice · doi:10.1177/08971900251319378 · Cited by 1
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023
Leinweber, M.-E., Taher, F., Assadian, A., & Hofmann, G. (2025) · Thrombosis Research · doi:10.1016/j.thromres.2025.109337 · Cited by 1
Bleeding Risk With Apixaban Versus Rivaroxaban: A Reference Trial Emulation Predicting the Results of COBRRA-VTE and COBRRA-AF Using US Health Care Claims
Mahesri, M., Schneeweiß, S., Lin, K. J., Zabotka, L., Concato, J., Bradley, M. C., & Wang, S. V. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012892 · Cited by 1
Point-of-care coagulometry in prehospital emergency patients – are international normalized ratios useful?
Struck, M. F., & Hilbert-Carius, P. (2016) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-015-0186-z · Cited by 1
Management of Traumatic Brain Injury in the Face of Antithrombotic Medication Therapy
DeAntonio, J. H., Means, K., Jayaraman, S., & Brophy, G. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-89477-5_16 · Cited by 1
Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
DiMaria, C. N., Hanna, W., Murone, J. N., & Reichart, J. (2019) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2019.230371rep · Cited by 1
Barriers to continued administration of direct oral anticoagulants between acute hospital and subacute or chronic hospitals and geriatric health services facilities in Japan
Akiyama, H., Nukui, S., & Hasegawa, Y. (2019) · Hospital Practice · doi:10.1080/21548331.2019.1684650 · Cited by 1
Reversal of anticoagulation in neurosurgical and neurocritical care settings
Lamperti, M., Jain, A. K., & Byrappa, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821776-4.00018-4 · Cited by 1
Use of Prothrombin Complex Concentrate in Oral Anticoagulant-Associated Major Bleeding
Lukas, J. G., Reichert, M. J., & Jones, G. M. (2022) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000399 · Cited by 1
Clotting Factor Concentrates
Arun, F., & Arun, O. (2022) · Springer eBooks · doi:10.1007/978-981-19-0954-2_30 · Cited by 1
Deep Vein Thrombosis and Pulmonary Embolism in Spinal Cord Injuries
Ko, H.-Y. (2022) · Springer eBooks · doi:10.1007/978-981-19-0228-4_26 · Cited by 1
Bleeding After Hemorrhoidectomy in Patients on Anticoagulation Medications
Kolbeinsson, H. M., Otto, M., Kogelschatz, B., Virk, U., Luchtefeld, M. A., & Ogilvie, J. W. (2022) · The American Surgeon · doi:10.1177/00031348221129512 · Cited by 1
Improving documentation of anticoagulation and antiplatelet recommendations after outpatient endoscopy
OʼConnell, B., Boyd, A., Kothari, D. J., Miller, N., Cornejo, J., & Sullivan, B. A. (2022) · BMJ Open Quality · doi:10.1136/bmjoq-2021-001725 · Cited by 1
The impact of oral anticoagulants on the characteristics of subdural hematomas and other brain lesions in patients with traumatic brain injury
Pastor, I.-S., Para, I., Vesa, Ș. C., & Florian, I. Ş. (2023) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2535 · Cited by 1
Propensity matched analysis examining the effect of passive reversal of direct oral anticoagulants on blood loss and the need for transfusions among traumatic geriatric hip fractures
Meinig, R. P., Jarvis, S., Salottolo, K., Nwafo, N., McNair, P. W., Harrison, P. D., Morgan, S., Duane, T. M., Woods, B., Nentwig, M., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01053-2 · Cited by 1
Outcomes of trauma patients on chronic antithrombotic therapies in a trauma center in a rural state
Moore, B., Jensen, H., Patel, K., Modi, Z. N., Reif, R., Lal, S., Bowman, S. M., Kost, M., Kalkwarf, K. J., Margolick, J. F., et al. (2023) · Surgery in Practice and Science · doi:10.1016/j.sipas.2023.100221 · Cited by 1
Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010–2020
Liaw, J., Liaw, D., & Dave, C. V. (2024) · Open Heart · doi:10.1136/openhrt-2023-002515 · Cited by 1
Uncovering the Role of Direct Oral Anticoagulants in Stroke Prevention for Atrial Fibrillation: A Review of the Literature
Rao, S., Aggarwal, S., Mani, S., Balasubramanian, A., & Veluswami, K. (2024) · Cureus · doi:10.7759/cureus.63675 · Cited by 1
Potential role of left atrial appendage closure in trauma patients with atrial fibrillation on anticoagulation
Azani, D. Z., Bhakta, H., Kazi, A., Woods, J., Love, B., & Jebbia, M. (2025) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2025-002042 · Cited by 1
Reversal agents for oral anticoagulants
Griffiths, C. L., Vestal, M. L., Livengood, S. J., & Hicks, S. (2017) · The Nurse Practitioner · doi:10.1097/01.npr.0000525714.86663.bd · Cited by 1
Antithrombotic treatment consensus protocol (anticoagulation and antiplatelet therapy) during the perioperative and periprocedural period in neurosurgery
Arikán, F., Urzaiz, L. L., Alén, J. F., & Laez, R. M. (2017) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2017.08.001 · Cited by 1
Evidence-Based Best Practices for Outpatient Management of Warfarin
Rose, A. J., & Vaiana, M. E. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018782473 · Cited by 1
Exploratory Ingestions of Novel Anticoagulants and Antiplatelets
Levine, M. P., Pizon, A. F., Beuhler, M. C., Cantrell, F. L., LoVecchio, F., Spyres, M. B., Skolnik, A. B., & Brooks, D. E. (2018) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001616 · Cited by 1
Anticoagulation Strategies for the Orthopaedic Surgeon: Reversal and Timelines.
Riedel, M. D., Watkins, I. T., McCormick, J. R., & Lancker, H. P. V. (2020) · PubMed Central · doi:10.22038/abjs.2019.44803.2222 · Cited by 1
Direct oral anticoagulant reversal
Hafer, A., & McCann, L. (2020) · Nursing Critical Care · doi:10.1097/01.ccn.0000718332.38919.36 · Cited by 1
Venous Thromboembolism in Spinal Cord Injuries
Ko, H.-Y., & Huh, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-3679-0_19 · Cited by 1
Frequency of Intracranial Hemorrhage among Patients with Skull Fractures in Blunt Head Trauma
Shoaib, M., Khan, S., Haq, N. U., Ullah, Z., Ali, S., Jamal, B., Ullah, I., & Shah, I. (2022) · American Journal of Health Medicine and Nursing Practice · doi:10.47672/ajhmn.980 · Cited by 1
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study
Sathanantham, V., Alberio, L., Bovet, C., Fontana, P., Gerber, B., Graf, L., Méndez, A., Sauter, T. C., Schmidt, A., Studt, J., et al. (2022) · Life · doi:10.3390/life12071027 · Cited by 1
Anticoagulants and Antiplatelet Agents in Cirrhosis
Su, F., & Northup, P. G. (2022) · Springer eBooks · doi:10.1007/978-981-19-2615-0_3 · Cited by 1
Herramientas para evaluar el conocimiento de los pacientes sobre su terapia anticoagulante
Mojica, A. M. P., Duarte-Osorio, A., & Vivas-Prieto, J. M. (2022) · Atención Familiar · doi:10.22201/fm.14058871p.2023.1.83871 · Cited by 1
Oral anticoagulant prescription for atrial fibrillation in the Veterans Administration Health System: National and international differences
Cairns, J. A. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.06.009 · Cited by 1
Letter by Jayaraman et al Regarding Articles, “Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants” and “Effectiveness and Safety of Oral Anticoagulants among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study”
Jayaraman, D. K., Alcusky, M. J., & Moonis, M. (2019) · Stroke · doi:10.1161/strokeaha.119.024817 · Cited by 1
Fluorine-doped LiNi{sub 0.5}Mn{sub 1.5}O{sub 4} for 5 V cathode materials of lithium-ion battery
Guodong, D., NuLi, Y., & Wang, J. (2008) · Materials Research Bulletin · Cited by 1
Annals for Hospitalists Inpatient Notes - Oral Anticoagulation for the Hospitalist—Expanded Choices Improve Patient-Centered Care
Barnes, G. D., & Paje, D. G. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1806
Self-citation
Should the Left Atrial Appendage Always be Removed in Mital Valve Surgery? In Search of a Perfect Outfit
(2017) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2017.08.00279
The changing landscape of anticoagulant-related intracerebral hemorrhage
Arsava, E. M., & Hall, C. B. (2017) · Neurology · doi:10.1212/wnl.0000000000003895
Novel Oral Anticoagulants in the Peri-Endoscopic Period
Genualdi, M. D., Lebovics, E., & Frishman, A. W. H. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000149
Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis
Ferahta, N., Kanagaratnam, L. K., Dramé, M., Vogel, T., Ambrosi, P.-J., & Lang, P.-O. (2017) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000048
Anticoagulation: The Successes and Pitfalls of Long-Term Management
Cucchi, E. W. (2017) · Physician Assistant Clinics · doi:10.1016/j.cpha.2017.06.003

Authors: Barnes, G. D., Lucas, E., Alexander, G. C., & Goldberger, Z. D.
Affiliations: University of Michigan (US)
Johns Hopkins University (US)
University of Washington (US)
Corresponding author: Barnes, Geoffrey D.
ORCID: Barnes, Geoffrey D.
Lucas, Eleanor
Alexander, G. Caleb
Goldberger, Zachary D.
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 2015-12
Volume: 128
Issue: 12
Pages: 1300-1305.e2
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/j.amjmed.2015.05.044
PMC: PMC4658248
OpenAlex: W826970266
Cited by: 598
References: 41
Citations by year: 2026: 11 · 2025: 25 · 2024: 23 · 2023: 38 · 2022: 72 · 2021: 69 · 2020: 87 · 2019: 97 · 2018: 83 · 2017: 61 · 2016: 29 · 2015: 1
FWCI: 42.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The American Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01 HL107345, T32 HL007853-16)
Portola Pharmaceuticals
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: direct oral anticoagulants, warfarin, atrial fibrillation, venous thromboembolism, outpatient care, rivaroxaban, apixaban, dabigatran, prescribing patterns, drug adoption
MeSH terms: Rivaroxaban, Dabigatran, Administration, Oral, Adult, Age Factors, Aged, Ambulatory Care, Anticoagulants, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Practice Patterns, Physicians', Pyrazoles, Pyridones, United States, Warfarin, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

National Trends in Ambulatory Oral Anticoagulant Use

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks